Afuco™ Anti-Human SLC2A8 ADCC Therapeutic Antibody (VB1-050), ADCC Enhanced
Anti-SLC2A8 ADCC Enhanced Antibody (VB1-050) is an ADCC enhanced antibody produced by our Afuco™ platform. VB1-050 is an IgG MAb generated from pooled lymphocytes of cancer patient samples, using standard hybridoma techniques. This antibody demonstrates preferential binding to a host of tumor cell lines, including breast, liver, prostate and colon, with limited normal tissue reactivity. Further research is ongoing to assess the potential clinical exploitation of VB1-050/Glut-8.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-551CL |
| Pricing | Inquiry |
| Host | Human |
| Target | SLC2A8 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at –20 or -70°C upon receipt. Divide antibody into aliquots prior usage and avoid multiple freeze-thaw cycles. |